Cash & equivalents increased 62.1%
Cash & equivalents changed +62.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +62.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -36.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -20.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed -20.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed +31.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current assets changed -17.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -31.2% from the comparable as-filed period.
Operating margin changed +1363333 basis points from the comparable as-filed period.
Revenue changed +200.0% from the comparable as-filed period.
Gross margin changed +33333 basis points from the comparable as-filed period.
Operating income changed -15.8% from the comparable as-filed period.
Selling, general & administrative changed +28.9% from the comparable as-filed period.
Capex / revenue changed +40000 basis points from the comparable as-filed period.
Cost of revenue changed +33.3% from the comparable as-filed period.
Capital expenditure changed +350.0% from the comparable as-filed period.
Operating cash flow changed -14.1% from the comparable as-filed period.
Net income changed -16.4% from the comparable as-filed period.
SBC / revenue changed -330000 basis points from the comparable as-filed period.
Research & development changed +13.4% from the comparable as-filed period.
R&D / revenue changed -1113333 basis points from the comparable as-filed period.
Free-cash-flow margin changed +883333 basis points from the comparable as-filed period.
Operating cash-flow margin changed +923333 basis points from the comparable as-filed period.
Stock-based compensation changed +5.9% from the comparable as-filed period.
Working capital / assets changed -23 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current liabilities changed +39.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -32.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -9.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -69.5% from the comparable as-filed period.
Operating cash flow changed -56.2% from the comparable as-filed period.
Cash & equivalents changed -34.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed -34.3% from the comparable as-filed period.
Operating margin changed +970000 basis points from the comparable as-filed period.
Gross margin changed +15000 basis points from the comparable as-filed period.
Revenue changed +100.0% from the comparable as-filed period.
Operating income changed -15.7% from the comparable as-filed period.
Selling, general & administrative changed +38.9% from the comparable as-filed period.
Capital expenditure changed +342.9% from the comparable as-filed period.
Current assets changed -6.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capex / revenue changed +85000 basis points from the comparable as-filed period.
Cost of revenue changed +40.0% from the comparable as-filed period.
SBC / revenue changed -250000 basis points from the comparable as-filed period.
Research & development changed +11.1% from the comparable as-filed period.
Free-cash-flow margin changed +230000 basis points from the comparable as-filed period.
Operating cash-flow margin changed +315000 basis points from the comparable as-filed period.
R&D / revenue changed -845000 basis points from the comparable as-filed period.
Working capital / assets changed -426 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +9.1% from the comparable as-filed period.
Total assets changed -2.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.